Tyrosine kinase inhibitor
CAS No. 1021950-26-4
Tyrosine kinase inhibitor ( —— )
产品货号. M26856 CAS No. 1021950-26-4
酪氨酸激酶抑制剂是一种酪氨酸激酶抑制剂,与片段化芳香族氮化合物联合用作抗增殖剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥1492 | 有现货 |
|
| 5MG | ¥2527 | 有现货 |
|
| 10MG | ¥3772 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥3259 | 有现货 |
|
生物学信息
-
产品名称Tyrosine kinase inhibitor
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述酪氨酸激酶抑制剂是一种酪氨酸激酶抑制剂,与片段化芳香族氮化合物联合用作抗增殖剂。
-
产品描述Tyrosine kinase inhibitor is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents.(In Vitro):Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli. Recent advances have implicated the role of tyrosine kinases in the pathophysiology of cancer. Though their activity is tightly regulated in normal cells, they may acquire transforming functions due to mutation(s), overexpression and autocrine paracrine stimulation, leading to malignancy. Constitutive oncogenic activation in cancer cells can be blocked by selective tyrosine kinase inhibitors and thus considered as a promising approach for innovative genome based therapeutics.
-
体外实验Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli.
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点c-Met/HGFR
-
受体Reactive Oxygen Species
-
研究领域——
-
适应症——
化学信息
-
CAS Number1021950-26-4
-
分子量586.624
-
分子式C31H31FN6O5
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : ≥ 46 mg/mL (78.42 mM)
-
SMILESFc1ccc(NC(=O)C2(CC2)C(=O)Nc2ccc(Oc3ccnc4[nH]c(cc34)C(=O)NCCN3CCOCC3)cc2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Suparna Qanungo, et al. N-Acetyl-L-cysteine Enhances Apoptosis Through Inhibition of Nuclear factor-kappaB in Hypoxic Murine Embryonic Fibroblasts. J Biol Chem
产品手册
关联产品
-
PF-04217903 methanes...
PF-04217903 是一种有效、选择性、ATP 竞争性 c-Met 激酶抑制剂,Ki 为 4.8 nM。
-
LMTK3-IN-1
LMTK3-IN-1 (compound C28) 是狐猴酪氨酸激酶 3 (LMTK3) (Kd=2.5 μM) 的 ATP 竞争性抑制剂,通过泛素蛋白酶体途径降解 LMTK3 发挥作用。LMTK3-IN-1 在多种癌细胞系和体内 BC 小鼠模型中显示出抗癌活性。10-20 μM LMTK3-IN-1 可诱导 BC 细胞系凋亡。
-
SAR125884
SAR125844 是一种有效且高度选择性的 MET 受体酪氨酸激酶 (RTK) 抑制剂,用于静脉内给药。 (IC50 值为 4.2 nmol/L)。
021-51111890
购物车()
sales@molnova.cn

